James Yan
Chief Tech/Sci/R&D Officer presso ZAI LAB LIMITED
Posizioni attive di James Yan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZAI LAB LIMITED | Chief Tech/Sci/R&D Officer | 01/04/2020 | - |
| Chinese Society of Toxicology | Corporate Officer/Principal | - | - |
Storia della carriera di James Yan
Precedenti posizioni note di James Yan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Formazione di James Yan
| Peking Union Medical College | Doctorate Degree |
Statistiche
Distribuzione geografica
| Cina | 4 |
| Isole Cayman | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Chinese Society of Toxicology |
- Borsa valori
- Insiders
- James Yan
- Esperienza
